Tag:
InnaVirVax
Latest Headlines
Latest Headlines
InnaVirVax nabs $4.9M in B round to advance HIV immunotherapy
French biotech InnaVirVax has rallied investors to pump $4.9 million into its coffers via a Series B round of financing. The company will use the proceeds to begin trials of its drug VAC-3S, which is
